Illumina to buy Menlo Park-based biotech for $1.2B
November 02, 2018 at 08:53 AM EDT
The all-cash transaction was set at a price of $8 per Pacific Biosciences share.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.